Buprenorphine in Dominica: not individually verified

Also known as: subutex

Not individually verified

We have not confirmed that Buprenorphine specifically is scheduled in Dominica, so this page gives no legal status. Publishing a guess here would be worse than publishing nothing. What we do know is the governing national drug law, below.

What is on record: Not confirmed. No entry for Buprenorphine was found in Part I, Part II or Part III of the Third Schedule to the Drugs (Prevention of Misuse) Act, Chapter 40:07, on a reading of the three complete printed lists as page images at the revision note «L.R.O. 1/1991» printed in the footer of those pages. The printed thebaine relatives are the Class A «Thebaine» and «Thebacon», and the Part I list also prints «Acetorphine» and «Etorphine», which are the oripavine derivatives this Schedule does carry. Buprenorphine is an oripavine derivative too and it is not printed, which is the point: the Schedule enumerates that family by name and stops before this member, so the omission is a gap in a list rather than a silence about a family. The absence is bounded by that revision and by nothing further: section 4(3) lets the Minister amend Parts I to III by Order after consulting the Advisory Council, Orders of that kind are published separately, and this consolidation reproduces none made after the note its Schedule pages carry. So about thirty five years of possible additions sit outside what was read, and that gap is why this row is left open here rather than published as a finding that the substance is uncontrolled in Dominica.

Confirm directly with Dominica’s national drug authority or your own embassy before you rely on anything.

What Dominica HAS confirmed for related substances

Codeinea related compound, not Buprenorphine
Codeine is a Class B controlled drug under the Drugs (Prevention of Misuse) Act, Chapter 40:07. Part II of the Third Schedule prints the entry «Codeine». The parent is a Class B entry, and the Class B list separately prints «Acetyldihydrocodeine», «Nicocodine», «Norcodeine» and «Diphydrocodeine», the last of those with the letters set as shown in the revised edition. Part II carries no strength or preparation exemption of the kind other Commonwealth schedules use for low dose codeine; its paragraph 4 reaches any preparation containing a paragraph 1 substance. Section 4(1)(a) makes a controlled drug any substance for the time being specified in Parts I, II or III of that Schedule and section 4(1)(b) makes a Class B drug any substance specified in Part II. Paragraph 3 of Part II extends the entry to any salt of the listed substance and paragraph 4 to any preparation or other product containing it. The placement is stated as at the revision this text carries: the Third Schedule occupies printed pages 30 to 33 and those pages are authorised by the footer note «L.R.O. 1/1991». Section 4(3) lets the Minister amend Parts I to III by Order after consulting the Advisory Council, and this consolidation reproduces no Order made after that authorisation, so the placement stated here is a floor and not a closed account of the position today. The compilation recorded «CODEÍNA» as the printed entry for this row. That string does not appear anywhere in this Act; the Act is written in English and that record's quotation column is largely in another language, which is a property of the record rather than of the instrument, so it is reported here and is not offered as a quotation from the Act.
Dominica, the Drugs (Prevention of Misuse) Act, Act 20 of 1988 as amended by Act 15 of 1989 and Act 15 of 1990, revised edition Chapter 40:07, sections 4, 5, 6, 7, 27, 29 and 32 and the Third and Fourth Schedules · read from the 64 page scanned chapter held in this repository at research/instruments/dominica/dm-drugs-prevention-of-misuse-1988.pdf, sha256 30ca6c954678725f8bd4ea81de7b081e5b3ef5ef9015d05e357de1992c62ab30, with its text layer at dm-drugs-prevention-of-misuse-1988.txt, sha256 d47a9b795cabe1a1250ebd6ec3e13e4ccb6367708b69fded78a8eb22b7ab1465. The entry relied on for this row is «Codeine» in Part II, read on printed page 32 as a page image rendered from the scan, because the text layer of this scan silently drops the «Part II» and «Part III» headings and one numbered paragraph in each of those Parts · the complete Class A, Class B and Class C lists were read that way and not by searching the text. The Third Schedule pages carry the footer «L.R.O. 1/1991» and the Fourth Schedule figures quoted here were read off the page images of printed pages 34 and 35. This citation is document level and not per substance: the compilation's links column for this row holds the constructed text «codeine national source» rather than an address, and no per row source exists. The compilation recorded «CODEÍNA» as the printed entry for this row. That string does not appear anywhere in this Act · the Act is written in English and that record's quotation column is largely in another language, which is a property of the record rather than of the instrument, so it is reported here and is not offered as a quotation from the Act. The Part and Class placement stated for this row is not printed in the quotation column of the compilation read alongside the Act: measured across that compilation, not one of its 88 rows carries a Part, a Class or a Schedule marker of any kind, and its instrument column says only that there is a controlled-drug schedule without naming which of the four Schedules that is. Every division named in this cell is therefore taken from the printed Third Schedule pages of the Act itself. Second instrument relied on: Dominica, the Drugs (Prevention of Misuse) (Amendment) Act 2020, Act No. 16 of 2020, assented to and gazetted 30 October 2020 and passed in the House of Assembly on 26 October 2020, a four page Act read in full from the Government of Dominica laws site at https://dominica.gov.dm/laws/2020/Drug%20Prevention%20(Amendment)%20Act%202020.pdf, sha256 c5f6a5b47cee1ffce3f88993d72163a1f0ba6a1f3cf68c31f8bfed89e1c5af01. It amends section 7(4), inserts sections 7A and 7B, amends section 8 and makes no amendment to the Third Schedule. Read as at 22 September 2026. · Verified September 21, 2026
Fentanyla related compound, not Buprenorphine
Fentanyl is a Class A controlled drug under the Drugs (Prevention of Misuse) Act, Chapter 40:07. Part I of the Third Schedule prints the entry «Fentanyl». The parent compound alone is printed. Part I carries no analogue clause and no family wording for this entry, and its paragraphs 2 to 5 reach only a stereoisomeric form, an ester, a salt and a preparation, so a ring substituted or amide modified fentanyl is not shown to be reached by the printed text. Section 4(1)(a) makes a controlled drug any substance for the time being specified in Parts I, II or III of that Schedule and section 4(1)(b) makes a Class A drug any substance specified in Part I. Paragraph 4 of Part I extends the entry to any salt of the listed substance and paragraph 5 to any preparation or other product containing it. The placement is stated as at the revision this text carries: the Third Schedule occupies printed pages 30 to 33 and those pages are authorised by the footer note «L.R.O. 1/1991». Section 4(3) lets the Minister amend Parts I to III by Order after consulting the Advisory Council, and this consolidation reproduces no Order made after that authorisation, so the placement stated here is a floor and not a closed account of the position today. The compilation recorded «FENTANILO» as the printed entry for this row. That string does not appear anywhere in this Act; the Act is written in English and that record's quotation column is largely in another language, which is a property of the record rather than of the instrument, so it is reported here and is not offered as a quotation from the Act.
Dominica, the Drugs (Prevention of Misuse) Act, Act 20 of 1988 as amended by Act 15 of 1989 and Act 15 of 1990, revised edition Chapter 40:07, sections 4, 5, 6, 7, 27, 29 and 32 and the Third and Fourth Schedules · read from the 64 page scanned chapter held in this repository at research/instruments/dominica/dm-drugs-prevention-of-misuse-1988.pdf, sha256 30ca6c954678725f8bd4ea81de7b081e5b3ef5ef9015d05e357de1992c62ab30, with its text layer at dm-drugs-prevention-of-misuse-1988.txt, sha256 d47a9b795cabe1a1250ebd6ec3e13e4ccb6367708b69fded78a8eb22b7ab1465. The entry relied on for this row is «Fentanyl» in Part I, read on printed page 30 or 31 as a page image rendered from the scan, because the text layer of this scan silently drops the «Part II» and «Part III» headings and one numbered paragraph in each of those Parts · the complete Class A, Class B and Class C lists were read that way and not by searching the text. The Third Schedule pages carry the footer «L.R.O. 1/1991» and the Fourth Schedule figures quoted here were read off the page images of printed pages 34 and 35. This citation is document level and not per substance: the compilation's links column for this row holds the constructed text «fentanyl national source» rather than an address, and no per row source exists. The compilation recorded «FENTANILO» as the printed entry for this row. That string does not appear anywhere in this Act · the Act is written in English and that record's quotation column is largely in another language, which is a property of the record rather than of the instrument, so it is reported here and is not offered as a quotation from the Act. The Part and Class placement stated for this row is not printed in the quotation column of the compilation read alongside the Act: measured across that compilation, not one of its 88 rows carries a Part, a Class or a Schedule marker of any kind, and its instrument column says only that there is a controlled-drug schedule without naming which of the four Schedules that is. Every division named in this cell is therefore taken from the printed Third Schedule pages of the Act itself. Second instrument relied on: Dominica, the Drugs (Prevention of Misuse) (Amendment) Act 2020, Act No. 16 of 2020, assented to and gazetted 30 October 2020 and passed in the House of Assembly on 26 October 2020, a four page Act read in full from the Government of Dominica laws site at https://dominica.gov.dm/laws/2020/Drug%20Prevention%20(Amendment)%20Act%202020.pdf, sha256 c5f6a5b47cee1ffce3f88993d72163a1f0ba6a1f3cf68c31f8bfed89e1c5af01. It amends section 7(4), inserts sections 7A and 7B, amends section 8 and makes no amendment to the Third Schedule. Read as at 22 September 2026. · Verified September 21, 2026
Heroina related compound, not Buprenorphine
Heroin is a Class A controlled drug under the Drugs (Prevention of Misuse) Act, Chapter 40:07. Part I of the Third Schedule prints the entry «Diamorphine». The Act prints the pharmacopoeial name and not the street one; section 7(4)(a) then prints «diacetylmorphine (heroin)» in its own threshold limb, which is the only place in the Chapter where the word heroin appears at all. Section 4(1)(a) makes a controlled drug any substance for the time being specified in Parts I, II or III of that Schedule and section 4(1)(b) makes a Class A drug any substance specified in Part I. Paragraph 4 of Part I extends the entry to any salt of the listed substance and paragraph 5 to any preparation or other product containing it. The placement is stated as at the revision this text carries: the Third Schedule occupies printed pages 30 to 33 and those pages are authorised by the footer note «L.R.O. 1/1991». Section 4(3) lets the Minister amend Parts I to III by Order after consulting the Advisory Council, and this consolidation reproduces no Order made after that authorisation, so the placement stated here is a floor and not a closed account of the position today. The compilation recorded «Diamorphine» as the printed entry for this row. That string is English and it is printed in the Act exactly as recorded, so it was checked against the page image and kept. It is one of only two strings in that record's whole quotation column that survives the check unaltered.
Dominica, the Drugs (Prevention of Misuse) Act, Act 20 of 1988 as amended by Act 15 of 1989 and Act 15 of 1990, revised edition Chapter 40:07, sections 4, 5, 6, 7, 27, 29 and 32 and the Third and Fourth Schedules · read from the 64 page scanned chapter held in this repository at research/instruments/dominica/dm-drugs-prevention-of-misuse-1988.pdf, sha256 30ca6c954678725f8bd4ea81de7b081e5b3ef5ef9015d05e357de1992c62ab30, with its text layer at dm-drugs-prevention-of-misuse-1988.txt, sha256 d47a9b795cabe1a1250ebd6ec3e13e4ccb6367708b69fded78a8eb22b7ab1465. The entry relied on for this row is «Diamorphine» in Part I, read on printed page 30 or 31 as a page image rendered from the scan, because the text layer of this scan silently drops the «Part II» and «Part III» headings and one numbered paragraph in each of those Parts · the complete Class A, Class B and Class C lists were read that way and not by searching the text. The Third Schedule pages carry the footer «L.R.O. 1/1991» and the Fourth Schedule figures quoted here were read off the page images of printed pages 34 and 35. This citation is document level and not per substance: the compilation's links column for this row holds the constructed text «heroin national source» rather than an address, and no per row source exists. The compilation recorded «Diamorphine» as the printed entry for this row. That string is English and it is printed in the Act exactly as recorded, so it was checked against the page image and kept. It is one of only two strings in that record's whole quotation column that survives the check unaltered. The Part and Class placement stated for this row is not printed in the quotation column of the compilation read alongside the Act: measured across that compilation, not one of its 88 rows carries a Part, a Class or a Schedule marker of any kind, and its instrument column says only that there is a controlled-drug schedule without naming which of the four Schedules that is. Every division named in this cell is therefore taken from the printed Third Schedule pages of the Act itself. Second instrument relied on: Dominica, the Drugs (Prevention of Misuse) (Amendment) Act 2020, Act No. 16 of 2020, assented to and gazetted 30 October 2020 and passed in the House of Assembly on 26 October 2020, a four page Act read in full from the Government of Dominica laws site at https://dominica.gov.dm/laws/2020/Drug%20Prevention%20(Amendment)%20Act%202020.pdf, sha256 c5f6a5b47cee1ffce3f88993d72163a1f0ba6a1f3cf68c31f8bfed89e1c5af01. It amends section 7(4), inserts sections 7A and 7B, amends section 8 and makes no amendment to the Third Schedule. Read as at 22 September 2026. · Verified September 21, 2026
Hydrocodonea related compound, not Buprenorphine
Hydrocodone is a Class A controlled drug under the Drugs (Prevention of Misuse) Act, Chapter 40:07. Part I of the Third Schedule prints the entry «Hydrocodone». The entry is printed in Part I between «Furethidine» and «Hydromorphinol», so it is a Class A drug in Dominica and not a Class B one; the Class B list prints «Codeine» and «Acetyldihydrocodeine» but no hydrocodone. Section 4(1)(a) makes a controlled drug any substance for the time being specified in Parts I, II or III of that Schedule and section 4(1)(b) makes a Class A drug any substance specified in Part I. Paragraph 4 of Part I extends the entry to any salt of the listed substance and paragraph 5 to any preparation or other product containing it. The placement is stated as at the revision this text carries: the Third Schedule occupies printed pages 30 to 33 and those pages are authorised by the footer note «L.R.O. 1/1991». Section 4(3) lets the Minister amend Parts I to III by Order after consulting the Advisory Council, and this consolidation reproduces no Order made after that authorisation, so the placement stated here is a floor and not a closed account of the position today. The compilation recorded «HIDROCODONA» as the printed entry for this row. That string does not appear anywhere in this Act; the Act is written in English and that record's quotation column is largely in another language, which is a property of the record rather than of the instrument, so it is reported here and is not offered as a quotation from the Act.
Dominica, the Drugs (Prevention of Misuse) Act, Act 20 of 1988 as amended by Act 15 of 1989 and Act 15 of 1990, revised edition Chapter 40:07, sections 4, 5, 6, 7, 27, 29 and 32 and the Third and Fourth Schedules · read from the 64 page scanned chapter held in this repository at research/instruments/dominica/dm-drugs-prevention-of-misuse-1988.pdf, sha256 30ca6c954678725f8bd4ea81de7b081e5b3ef5ef9015d05e357de1992c62ab30, with its text layer at dm-drugs-prevention-of-misuse-1988.txt, sha256 d47a9b795cabe1a1250ebd6ec3e13e4ccb6367708b69fded78a8eb22b7ab1465. The entry relied on for this row is «Hydrocodone» in Part I, read on printed page 30 or 31 as a page image rendered from the scan, because the text layer of this scan silently drops the «Part II» and «Part III» headings and one numbered paragraph in each of those Parts · the complete Class A, Class B and Class C lists were read that way and not by searching the text. The Third Schedule pages carry the footer «L.R.O. 1/1991» and the Fourth Schedule figures quoted here were read off the page images of printed pages 34 and 35. This citation is document level and not per substance: the compilation's links column for this row holds the constructed text «hydrocodone national source» rather than an address, and no per row source exists. The compilation recorded «HIDROCODONA» as the printed entry for this row. That string does not appear anywhere in this Act · the Act is written in English and that record's quotation column is largely in another language, which is a property of the record rather than of the instrument, so it is reported here and is not offered as a quotation from the Act. The Part and Class placement stated for this row is not printed in the quotation column of the compilation read alongside the Act: measured across that compilation, not one of its 88 rows carries a Part, a Class or a Schedule marker of any kind, and its instrument column says only that there is a controlled-drug schedule without naming which of the four Schedules that is. Every division named in this cell is therefore taken from the printed Third Schedule pages of the Act itself. Second instrument relied on: Dominica, the Drugs (Prevention of Misuse) (Amendment) Act 2020, Act No. 16 of 2020, assented to and gazetted 30 October 2020 and passed in the House of Assembly on 26 October 2020, a four page Act read in full from the Government of Dominica laws site at https://dominica.gov.dm/laws/2020/Drug%20Prevention%20(Amendment)%20Act%202020.pdf, sha256 c5f6a5b47cee1ffce3f88993d72163a1f0ba6a1f3cf68c31f8bfed89e1c5af01. It amends section 7(4), inserts sections 7A and 7B, amends section 8 and makes no amendment to the Third Schedule. Read as at 22 September 2026. · Verified September 21, 2026
Methadonea related compound, not Buprenorphine
Methadone is a Class A controlled drug under the Drugs (Prevention of Misuse) Act, Chapter 40:07. Part I of the Third Schedule prints the entry «Methadone». The Part I list prints the parent beside «Methadyl acetate», «Alphamethadol», «Betamethadol» and «Noracymethadol», each as its own entry, so the methadol family is enumerated rather than left to a generic clause and this row rests on the parent line only. Section 4(1)(a) makes a controlled drug any substance for the time being specified in Parts I, II or III of that Schedule and section 4(1)(b) makes a Class A drug any substance specified in Part I. Paragraph 4 of Part I extends the entry to any salt of the listed substance and paragraph 5 to any preparation or other product containing it. The placement is stated as at the revision this text carries: the Third Schedule occupies printed pages 30 to 33 and those pages are authorised by the footer note «L.R.O. 1/1991». Section 4(3) lets the Minister amend Parts I to III by Order after consulting the Advisory Council, and this consolidation reproduces no Order made after that authorisation, so the placement stated here is a floor and not a closed account of the position today. The compilation read for this row recorded no printed entry claim, so nothing from it was carried across.
Dominica, the Drugs (Prevention of Misuse) Act, Act 20 of 1988 as amended by Act 15 of 1989 and Act 15 of 1990, revised edition Chapter 40:07, sections 4, 5, 6, 7, 27, 29 and 32 and the Third and Fourth Schedules · read from the 64 page scanned chapter held in this repository at research/instruments/dominica/dm-drugs-prevention-of-misuse-1988.pdf, sha256 30ca6c954678725f8bd4ea81de7b081e5b3ef5ef9015d05e357de1992c62ab30, with its text layer at dm-drugs-prevention-of-misuse-1988.txt, sha256 d47a9b795cabe1a1250ebd6ec3e13e4ccb6367708b69fded78a8eb22b7ab1465. The entry relied on for this row is «Methadone» in Part I, read on printed page 30 or 31 as a page image rendered from the scan, because the text layer of this scan silently drops the «Part II» and «Part III» headings and one numbered paragraph in each of those Parts · the complete Class A, Class B and Class C lists were read that way and not by searching the text. The Third Schedule pages carry the footer «L.R.O. 1/1991» and the Fourth Schedule figures quoted here were read off the page images of printed pages 34 and 35. This citation is document level and not per substance: the compilation's links column for this row holds the constructed text «methadone national source» rather than an address, and no per row source exists. The compilation read for this row recorded no printed entry claim, so nothing from it was carried across. The Part and Class placement stated for this row is not printed in the quotation column of the compilation read alongside the Act: measured across that compilation, not one of its 88 rows carries a Part, a Class or a Schedule marker of any kind, and its instrument column says only that there is a controlled-drug schedule without naming which of the four Schedules that is. Every division named in this cell is therefore taken from the printed Third Schedule pages of the Act itself. Second instrument relied on: Dominica, the Drugs (Prevention of Misuse) (Amendment) Act 2020, Act No. 16 of 2020, assented to and gazetted 30 October 2020 and passed in the House of Assembly on 26 October 2020, a four page Act read in full from the Government of Dominica laws site at https://dominica.gov.dm/laws/2020/Drug%20Prevention%20(Amendment)%20Act%202020.pdf, sha256 c5f6a5b47cee1ffce3f88993d72163a1f0ba6a1f3cf68c31f8bfed89e1c5af01. It amends section 7(4), inserts sections 7A and 7B, amends section 8 and makes no amendment to the Third Schedule. Read as at 22 September 2026. · Verified September 21, 2026
Morphinea related compound, not Buprenorphine
Morphine is a Class A controlled drug under the Drugs (Prevention of Misuse) Act, Chapter 40:07. Part I of the Third Schedule prints the entry «Morphine». The parent entry is printed alone, and the Part I list separately prints «Morphine methobromide, morphine N-oxide and other pentavalent nitrogen morphine derivatives» and «Dihydromorphine», so the pentavalent group and the dihydro compound are their own entries and are not folded into this one. Section 4(1)(a) makes a controlled drug any substance for the time being specified in Parts I, II or III of that Schedule and section 4(1)(b) makes a Class A drug any substance specified in Part I. Paragraph 4 of Part I extends the entry to any salt of the listed substance and paragraph 5 to any preparation or other product containing it. The placement is stated as at the revision this text carries: the Third Schedule occupies printed pages 30 to 33 and those pages are authorised by the footer note «L.R.O. 1/1991». Section 4(3) lets the Minister amend Parts I to III by Order after consulting the Advisory Council, and this consolidation reproduces no Order made after that authorisation, so the placement stated here is a floor and not a closed account of the position today. The compilation recorded «MORFINA» as the printed entry for this row. That string does not appear anywhere in this Act; the Act is written in English and that record's quotation column is largely in another language, which is a property of the record rather than of the instrument, so it is reported here and is not offered as a quotation from the Act.
Dominica, the Drugs (Prevention of Misuse) Act, Act 20 of 1988 as amended by Act 15 of 1989 and Act 15 of 1990, revised edition Chapter 40:07, sections 4, 5, 6, 7, 27, 29 and 32 and the Third and Fourth Schedules · read from the 64 page scanned chapter held in this repository at research/instruments/dominica/dm-drugs-prevention-of-misuse-1988.pdf, sha256 30ca6c954678725f8bd4ea81de7b081e5b3ef5ef9015d05e357de1992c62ab30, with its text layer at dm-drugs-prevention-of-misuse-1988.txt, sha256 d47a9b795cabe1a1250ebd6ec3e13e4ccb6367708b69fded78a8eb22b7ab1465. The entry relied on for this row is «Morphine» in Part I, read on printed page 30 or 31 as a page image rendered from the scan, because the text layer of this scan silently drops the «Part II» and «Part III» headings and one numbered paragraph in each of those Parts · the complete Class A, Class B and Class C lists were read that way and not by searching the text. The Third Schedule pages carry the footer «L.R.O. 1/1991» and the Fourth Schedule figures quoted here were read off the page images of printed pages 34 and 35. This citation is document level and not per substance: the compilation's links column for this row holds the constructed text «morphine national source» rather than an address, and no per row source exists. The compilation recorded «MORFINA» as the printed entry for this row. That string does not appear anywhere in this Act · the Act is written in English and that record's quotation column is largely in another language, which is a property of the record rather than of the instrument, so it is reported here and is not offered as a quotation from the Act. The Part and Class placement stated for this row is not printed in the quotation column of the compilation read alongside the Act: measured across that compilation, not one of its 88 rows carries a Part, a Class or a Schedule marker of any kind, and its instrument column says only that there is a controlled-drug schedule without naming which of the four Schedules that is. Every division named in this cell is therefore taken from the printed Third Schedule pages of the Act itself. Second instrument relied on: Dominica, the Drugs (Prevention of Misuse) (Amendment) Act 2020, Act No. 16 of 2020, assented to and gazetted 30 October 2020 and passed in the House of Assembly on 26 October 2020, a four page Act read in full from the Government of Dominica laws site at https://dominica.gov.dm/laws/2020/Drug%20Prevention%20(Amendment)%20Act%202020.pdf, sha256 c5f6a5b47cee1ffce3f88993d72163a1f0ba6a1f3cf68c31f8bfed89e1c5af01. It amends section 7(4), inserts sections 7A and 7B, amends section 8 and makes no amendment to the Third Schedule. Read as at 22 September 2026. · Verified September 21, 2026
Oxycodonea related compound, not Buprenorphine
Oxycodone is a Class A controlled drug under the Drugs (Prevention of Misuse) Act, Chapter 40:07. Part I of the Third Schedule prints the entry «Oxycodone». The entry sits between «Opium, whether raw, prepared of medicinal» and «Oxymorphone» in the Part I column, so the two oxy compounds are printed as separate entries and neither is reached through the other. Section 4(1)(a) makes a controlled drug any substance for the time being specified in Parts I, II or III of that Schedule and section 4(1)(b) makes a Class A drug any substance specified in Part I. Paragraph 4 of Part I extends the entry to any salt of the listed substance and paragraph 5 to any preparation or other product containing it. The placement is stated as at the revision this text carries: the Third Schedule occupies printed pages 30 to 33 and those pages are authorised by the footer note «L.R.O. 1/1991». Section 4(3) lets the Minister amend Parts I to III by Order after consulting the Advisory Council, and this consolidation reproduces no Order made after that authorisation, so the placement stated here is a floor and not a closed account of the position today. The compilation recorded «OXICODONA» as the printed entry for this row. That string does not appear anywhere in this Act; the Act is written in English and that record's quotation column is largely in another language, which is a property of the record rather than of the instrument, so it is reported here and is not offered as a quotation from the Act.
Dominica, the Drugs (Prevention of Misuse) Act, Act 20 of 1988 as amended by Act 15 of 1989 and Act 15 of 1990, revised edition Chapter 40:07, sections 4, 5, 6, 7, 27, 29 and 32 and the Third and Fourth Schedules · read from the 64 page scanned chapter held in this repository at research/instruments/dominica/dm-drugs-prevention-of-misuse-1988.pdf, sha256 30ca6c954678725f8bd4ea81de7b081e5b3ef5ef9015d05e357de1992c62ab30, with its text layer at dm-drugs-prevention-of-misuse-1988.txt, sha256 d47a9b795cabe1a1250ebd6ec3e13e4ccb6367708b69fded78a8eb22b7ab1465. The entry relied on for this row is «Oxycodone» in Part I, read on printed page 30 or 31 as a page image rendered from the scan, because the text layer of this scan silently drops the «Part II» and «Part III» headings and one numbered paragraph in each of those Parts · the complete Class A, Class B and Class C lists were read that way and not by searching the text. The Third Schedule pages carry the footer «L.R.O. 1/1991» and the Fourth Schedule figures quoted here were read off the page images of printed pages 34 and 35. This citation is document level and not per substance: the compilation's links column for this row holds the constructed text «oxycodone national source» rather than an address, and no per row source exists. The compilation recorded «OXICODONA» as the printed entry for this row. That string does not appear anywhere in this Act · the Act is written in English and that record's quotation column is largely in another language, which is a property of the record rather than of the instrument, so it is reported here and is not offered as a quotation from the Act. The Part and Class placement stated for this row is not printed in the quotation column of the compilation read alongside the Act: measured across that compilation, not one of its 88 rows carries a Part, a Class or a Schedule marker of any kind, and its instrument column says only that there is a controlled-drug schedule without naming which of the four Schedules that is. Every division named in this cell is therefore taken from the printed Third Schedule pages of the Act itself. Second instrument relied on: Dominica, the Drugs (Prevention of Misuse) (Amendment) Act 2020, Act No. 16 of 2020, assented to and gazetted 30 October 2020 and passed in the House of Assembly on 26 October 2020, a four page Act read in full from the Government of Dominica laws site at https://dominica.gov.dm/laws/2020/Drug%20Prevention%20(Amendment)%20Act%202020.pdf, sha256 c5f6a5b47cee1ffce3f88993d72163a1f0ba6a1f3cf68c31f8bfed89e1c5af01. It amends section 7(4), inserts sections 7A and 7B, amends section 8 and makes no amendment to the Third Schedule. Read as at 22 September 2026. · Verified September 21, 2026

This page is deliberately excluded from search indexing and from our sitemap. Only confirmed, individually verified statuses are published as indexable pages.

Before you travel

Verify current rules with the destination country’s official drug authority and your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.

If you’re detained or arrested abroad

Contact your own country’s embassy or consulate in the destination immediately, not the destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →

← Buprenorphine in every country All substances in Dominica